Kathleen A. Ross Department of Chemical and Biological Engineering, College of Engineering Iowa State University Biography Publications Institution JoVE Articles Kathleen A. Ross has not added a biography. If you are Kathleen A. Ross and would like to personalize this page please email our Author Liaison for assistance. Publications Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection Against Respiratory Syncytial Virus Journal of Immunology (Baltimore, Md. : 1950). May, 2021 | Pubmed ID: 33827894 Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles Current Topics in Microbiology and Immunology. Nov, 2020 | Pubmed ID: 33165869 Pentaerythritol-based Lipid A Bolsters the Antitumor Efficacy of a Polyanhydride Particle-based Cancer Vaccine Nanomedicine : Nanotechnology, Biology, and Medicine. 10, 2019 | Pubmed ID: 31319179 Effective Mosaic-based Nanovaccines Against Avian Influenza in Poultry Vaccine. 08, 2019 | Pubmed ID: 31300285 Amphiphilic Polyanhydride-based Recombinant MUC4β-nanovaccine Activates Dendritic Cells Genes & Cancer. May, 2019 | Pubmed ID: 31258832 Interleukin-1 Alpha Increases Anti-tumor Efficacy of Cetuximab in Head and Neck Squamous Cell Carcinoma Journal for Immunotherapy of Cancer. 03, 2019 | Pubmed ID: 30890189 Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses The Journal of Pharmacology and Experimental Therapeutics. 09, 2019 | Pubmed ID: 30361239 Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections Frontiers in Immunology. 2018 | Pubmed ID: 30233573 PH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles Biomacromolecules. 03, 2018 | Pubmed ID: 29443509 Emerging Trends in the Immunotherapy of Pancreatic Cancer Cancer Letters. 03, 2018 | Pubmed ID: 29242097 Nano-enabled Delivery of Diverse Payloads Across Complex Biological Barriers Journal of Controlled Release : Official Journal of the Controlled Release Society. Dec, 2015 | Pubmed ID: 26315817 Hemagglutinin-based Polyanhydride Nanovaccines Against H5N1 Influenza Elicit Protective Virus Neutralizing Titers and Cell-mediated Immunity International Journal of Nanomedicine. 2015 | Pubmed ID: 25565816 Effect of Nanovaccine Chemistry on Humoral Immune Response Kinetics and Maturation Nanoscale. Nov, 2014 | Pubmed ID: 25285425 Lung Deposition and Cellular Uptake Behavior of Pathogen-mimicking Nanovaccines in the First 48 Hours Advanced Healthcare Materials. Jul, 2014 | Pubmed ID: 24520022 Structural and Antigenic Stability of H5N1 Hemagglutinin Trimer Upon Release from Polyanhydride Nanoparticles Journal of Biomedical Materials Research. Part A. Nov, 2014 | Pubmed ID: 24443139 Evaluation of Biocompatibility and Administration Site Reactogenicity of Polyanhydride-particle-based Platform for Vaccine Delivery Advanced Healthcare Materials. Feb, 2013 | Pubmed ID: 23184561 Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles M. M. Hasibuzzaman1,2, Kathleen A. Ross3,4, Aliasger K. Salem1,4,5,6, Balaji Narasimhan3,4, Andrean L. Simons1,2,3,5,6,7 1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, 2Department of Pathology, University of Iowa, 3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University, 4Nanovaccine Institute, Iowa State University, 5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, 6Holden Comprehensive Cancer Center, University of Iowa, 7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa JoVE 62683 Recherche en cancérologie
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles M. M. Hasibuzzaman1,2, Kathleen A. Ross3,4, Aliasger K. Salem1,4,5,6, Balaji Narasimhan3,4, Andrean L. Simons1,2,3,5,6,7 1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, 2Department of Pathology, University of Iowa, 3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University, 4Nanovaccine Institute, Iowa State University, 5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, 6Holden Comprehensive Cancer Center, University of Iowa, 7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa JoVE 62683 Recherche en cancérologie